PLAU and breast carcinoma: In breast carcinoma cells, Int6 depletion induces diminished proliferation, decreasing urokinase-type plasminogen activator (PLAU) and apoptotic regulator BCL-XL [18], and favors epithelial-to-mesenchymal transition increasing Snail and Zeb2 expression [19].